Dr. Belen Pascual, PhD
Claim this profileNantz National Alzheimer Center Houston
Studies Frontotemporal Dementia
Studies Semantic Dementia
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Belen Pascual, PhD is currently running
Verdiperstat
for Frontotemporal Dementia
This trial tests the safety of Verdiperstat, a medication taken regularly, in patients with language difficulties caused by brain issues. The study aims to see if the drug can change protein levels in the brain and improve cognitive functions.
Recruiting0 awards Phase 111 criteria
Research
for Frontotemporal Dementia
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.
Recruiting1 award N/A10 criteria
More about Belen Pascual, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Belen Pascual, PhD has experience with
- Verdiperstat
- 18F-Flortaucipir Radiopharmaceutical
- 18F-MK-6240 Radiopharmaceutical
- Amyloid-β Radiopharmaceutical (11C-PiB Or 18F-Florbetaben Or 18F-NAV-4694)
Breakdown of trials Belen Pascual, PhD has run
Frontotemporal Dementia
Amyotrophic Lateral Sclerosis
Cortical Basal Ganglionic Degeneration
Progressive Supranuclear Palsy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Belen Pascual, PhD specialize in?
Belen Pascual, PhD focuses on Frontotemporal Dementia and Semantic Dementia. In particular, much of their work with Frontotemporal Dementia has involved treating patients, or patients who are undergoing treatment.
Is Belen Pascual, PhD currently recruiting for clinical trials?
Yes, Belen Pascual, PhD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Belen Pascual, PhD has studied deeply?
Yes, Belen Pascual, PhD has studied treatments such as Verdiperstat, 18F-Flortaucipir radiopharmaceutical, 18F-MK-6240 radiopharmaceutical.
What is the best way to schedule an appointment with Belen Pascual, PhD?
Apply for one of the trials that Belen Pascual, PhD is conducting.
What is the office address of Belen Pascual, PhD?
The office of Belen Pascual, PhD is located at: Nantz National Alzheimer Center Houston, Houston, Texas 77030 United States. This is the address for their practice at the Nantz National Alzheimer Center Houston.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.